PT100284A - Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos - Google Patents

Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos

Info

Publication number
PT100284A
PT100284A PT100284A PT10028492A PT100284A PT 100284 A PT100284 A PT 100284A PT 100284 A PT100284 A PT 100284A PT 10028492 A PT10028492 A PT 10028492A PT 100284 A PT100284 A PT 100284A
Authority
PT
Portugal
Prior art keywords
treatment
pct
microsporide
helmintic
medication
Prior art date
Application number
PT100284A
Other languages
English (en)
Other versions
PT100284B (pt
Inventor
Brian G Gazzard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT100284A publication Critical patent/PT100284A/pt
Publication of PT100284B publication Critical patent/PT100284B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
PT100284A 1991-03-25 1992-03-24 Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos PT100284B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106278A GB9106278D0 (en) 1991-03-25 1991-03-25 Method of treatment

Publications (2)

Publication Number Publication Date
PT100284A true PT100284A (pt) 1993-06-30
PT100284B PT100284B (pt) 1999-08-31

Family

ID=10692149

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100284A PT100284B (pt) 1991-03-25 1992-03-24 Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos

Country Status (18)

Country Link
US (1) US5432187A (pt)
EP (1) EP0576506B1 (pt)
JP (1) JPH06505733A (pt)
KR (1) KR100227125B1 (pt)
AT (1) ATE174507T1 (pt)
AU (1) AU657317B2 (pt)
CA (1) CA2103787A1 (pt)
DE (1) DE69227899T2 (pt)
DK (1) DK0576506T3 (pt)
ES (1) ES2125890T3 (pt)
GB (1) GB9106278D0 (pt)
GR (1) GR3029357T3 (pt)
HK (1) HK1012238A1 (pt)
IE (1) IE920930A1 (pt)
MX (1) MX9201288A (pt)
PT (1) PT100284B (pt)
WO (1) WO1992016208A1 (pt)
ZA (1) ZA922102B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
WO1998000018A1 (en) * 1996-07-03 1998-01-08 Prm Pharmaceuticals, Inc. Berberine alkaloids as a treatment for chronic, protozoally-induced diarrhea
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4761M (pt) * 1965-08-05 1967-01-16
US3915986A (en) * 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate

Also Published As

Publication number Publication date
JPH06505733A (ja) 1994-06-30
MX9201288A (es) 1992-10-01
GR3029357T3 (en) 1999-05-28
GB9106278D0 (en) 1991-05-08
US5432187A (en) 1995-07-11
EP0576506A1 (en) 1994-01-05
HK1012238A1 (en) 1999-07-30
ES2125890T3 (es) 1999-03-16
EP0576506B1 (en) 1998-12-16
IE920930A1 (en) 1992-10-07
ATE174507T1 (de) 1999-01-15
WO1992016208A1 (en) 1992-10-01
DE69227899D1 (de) 1999-01-28
DK0576506T3 (da) 1999-08-23
KR100227125B1 (ko) 1999-10-15
CA2103787A1 (en) 1992-09-26
DE69227899T2 (de) 1999-07-01
AU657317B2 (en) 1995-03-09
AU1550092A (en) 1992-10-21
ZA922102B (en) 1993-09-23
PT100284B (pt) 1999-08-31

Similar Documents

Publication Publication Date Title
ES2058892T3 (es) Uso de omeprazol como agente antimicrobiano.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
GEP19981482B (en) Use of 1,3 - Oxatiolan Nucleozides Analoges for Treatment of Hepatitis B
CL2008003939A1 (es) Uso de escitalopram o una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento de ansiedad social (divisional de la solicitud 1799-00).
ATE259815T1 (de) Neue antagonistische verbindungen
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
PT100284A (pt) Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos
DK0681473T3 (da) Præparater, der indeholder tandospiron eller dets analoger
MC1930A1 (fr) Produit antiviral
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
UY27372A1 (es) Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
ES2049711T3 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de cistinuria.
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
ES2160927T3 (es) Composiciones farmaceuticas que comprenden interferon alfa humano natural.
MX9203068A (es) Compuestos activirales oralmente activos.
BR0112874A (pt) Uso de fribratos para a preparação de um medicamento útil no tratamento de falha de coração congestiva
BR0109345A (pt) Compostos com atividade anti-hiv
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
ES2093515T3 (es) Aplicacion del riluzol como radio-restaurador.
FI952855A0 (fi) Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930219

FG3A Patent granted, date of granting

Effective date: 19990520

MM3A Annulment or lapse

Effective date: 20041122